Leo KoGuan, billionaire entrepreneur and founder of SHI International, built one of America’s largest privately held IT services companies, supplying software, cloud infrastructure, and enterprise solutions to Fortune 500 clients. A bold technology investor, he is also known as one of the biggest individual shareholders of Tesla, publicly advocating for the company’s mission and long-term strategy. Born in Indonesia and educated in the United States, KoGuan combines global business reach with significant philanthropy, supporting universities, research, and cultural institutions across Asia and the U.S. His career reflects scale, conviction, and a relentless focus on technological progress.

Kelcy Warren, cofounder and executive chairman of Energy Transfer, built one of North America’s largest pipeline and midstream energy networks through aggressive dealmaking, operational scale, and a deep understanding of U.S. oil and gas logistics. Since launching Energy Transfer in 1996, he has overseen a sweeping expansion across natural gas, crude, and NGL infrastructure, including the development of high-profile projects such as the Dakota Access Pipeline. A self-made billionaire from modest Texas roots, Warren combines engineering discipline with bold acquisitive strategy, while remaining an active philanthropist in education, parks, and music—most notably founding the Texas music venue and nonprofit, Klyde Warren Park in Dallas.

James Y. Chao, co-founder and chairman of Westlake Corporation, has built the Houston-based chemicals and materials company into a global industrial leader. Since establishing Westlake in 1986, he has overseen its growth into a multibillion-dollar enterprise producing petrochemicals, polymers, and building products with operations across North America, Europe, and Asia. Known for his strategic discipline and long-term vision, Chao has guided the company’s expansion through innovation, acquisitions, and a strong family-led culture, making Westlake a cornerstone of the global chemicals and construction materials industry.

Dr. Hao Hong, founder, chairman, and CEO of Asymchem Laboratories, has built the company into a leading global contract development and manufacturing organization (CDMO) serving the pharmaceutical industry. Since establishing the firm in 1997, he has guided its expansion into advanced R&D services, green chemistry solutions, and large-scale manufacturing for biotech and pharma clients worldwide. With a focus on innovation, efficiency, and sustainability, Hong has positioned Asymchem as a key partner in accelerating drug development and advancing healthcare globally.

Boliang Lou is a Chinese-American entrepreneur, co-founder and CEO of Pharmaron, a leading global contract research and development firm in pharma services established in 2003. A PhD in organic chemistry and former research head at Advanced SynTech, Lou expanded Pharmaron into a multinational enterprise recognized for innovation (e.g., Beijing Overseas Returnee Entrepreneur awards) and strategic partnerships in biotech.